Drug-induced pulmonary artery hypertension
Open Access
- 1 May 2022
- journal article
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 1,p. 53-63
- https://doi.org/10.37489/2588-0519-2022-1-53-63
Abstract
Pulmonary arterial hypertension is a condition characterized by an increase in mean pressure in the pulmonary artery. This pathology is associated with high mortality, and specific therapy for pulmonary arterial hypertension does not affect the cause of the disease and is extremely expensive. In this regard, it is especially important to study the modifiable etiological factors of pulmonary arterial hypertension. One such factor is drugs. One of the leading groups of drugs-inductors is anorexigenic drugs. It was the representatives of this group, such as aminorex, who were the first inducers of pulmonary hypertension. Moreover, this adverse reaction was so significant that it led to the withdrawal of these drugs. Currently, the leading role in the context of drug-induced pulmonary hypertension is played by such drugs as anticancer, antiviral drugs, and interferons. These drugs lead to pulmonary hypertension through various pathophysiological mechanisms. The leading measures to prevent this pathology are to limit the use of culprit medications, reduce the spread of HIV infection, since several groups of drugs can be used to treat HIV-infected patients, leading to the development of pulmonary hypertension.Keywords
This publication has 74 references indexed in Scilit:
- Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibitionEuropean Respiratory Journal, 2013
- Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertensionCardiovascular Research, 2013
- Endothelin‐1 as a Mediator and Potential Biomarker for Interferon Induced Pulmonary ToxicityPulmonary Circulation, 2012
- Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-upAIDS, 2012
- Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in HumansJournal of Clinical Medicine Research, 2011
- Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis CDigestive Diseases and Sciences, 2010
- Non-thromboembolic pulmonary hypertension in multiple myeloma, after thalidomide treatment: A pilot studyAnnals of Oncology, 2008
- Temporal trends and drug exposures in pulmonary hypertension: An American experienceAmerican Heart Journal, 2006
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionThe New England Journal of Medicine, 1996
- Cocaine-stimulated endothelin-1 release is decreased by angiotensin-converting enzyme inhibitors in cultured endothelial cellsCardiovascular Research, 1996